Starting this week, the company said it will no longer sell certain Acuson ultrasound carts, including its Sequoia, Redwood, Juniper and Maple models designed for a variety of specialities and clinical settings.
Instead it will move forward with its Acuson Freestyle wireless point-of-care probes, as well as the Acuson Origin line for cardiovascular imaging, which supports catheter-driven intracardiac echocardiography, or ICE, for valve implantations, ablations and other interventions.
“Medicine is evolving, and imaging is increasingly becoming part of therapy, not just diagnosis,” Siemens Healthineers’ ultrasound head, Sourabh Pagaria, said in a statement. “By concentrating our ultrasound portfolio on procedural imaging, we can apply our strengths in advanced cardiovascular imaging, ICE, software, AI, and partnerships with cardiovascular device companies to address important clinical needs and create long-term value for physicians, patients, and Siemens Healthineers.”
Related: FDA clears Siemens Healthineers’ AI-powered cardiovascular ultrasound and catheter
The company said it will continue to provide service and support for its previous customers, including software updates and transducer replacements, and honor its contractual and regulatory obligations.
Siemens Healthineers described the general ultrasound market as well-served, with multiple established providers.
